Intellectual Property: A Strategic and Valuable Asset
Join patent attorneys Dr Veronika Brázdová (deeptech) and Dr Rose Hughes (biotech) for a practical and interactive session designed for academics and start-up founders.
What the session will cover:
- An introduction to the different types of intellectual property (IP) and how they apply to research and innovation
- Understanding freedom to operate and why it matters when commercialising technology
- How to position and leverage IP strategically when seeking investment
- Key differences in IP strategy between the high-tech and biotech sectors
- Practical insights tailored to early-stage ventures and university spin-outs
Format
- Practical, real-world examples
- Sector-specific perspectives (physics/high-tech and biotech)
- Interactive discussion
- Dedicated time for Q&A
Learn more about the Industry & Enterprise Programme here.
Please sign up for the event here.
Speakers:
Dr Veronika Brázdová is a patent attorney with a PhD in computational physics and a decade of postdoctoral research at UCL. After transitioning into intellectual property, she founded her own practice where she specialises in sustainable marine technologies and draws on her expertise in supporting start-ups and developing commercially aligned IP strategies.
Dr Rose Hughes (MA (Cantab), PhD, EPA) brings passion for effective IP strategy in pharmaceuticals to biopharma specialist firm Evolve Intellectual Property. With a PhD in Immunology (UCL) and over a decade of patent experience, she combines scientific expertise with practical IP solutions. Formerly Patent Director at AstraZeneca, Rose has led IP strategy for pharma products across the pipeline, including on-market biologics and cell therapy platforms. Her unique blend of law firm and in-house experience enables her to develop innovative IP strategies that deliver genuine business value. Rose is also a leading contributor to IPKat, one of Europe’s leading IP blogs, writing on patents, AI and pharma IP strategy.
